Recent BYU-Graduates Receive FDA Emergency Use Authorization for COVID-19 Ventilator

For immediate release, 6/22/20

Within weeks of hearing of projected ventilator shortages in the United States, the team at NeoNatal Rescue modified their existing newborn ventilator device to treat adult patients with COVID-19 and submit for FDA approval.

Provo, Utah: Utah-based organization NeoNatal Rescue received FDA Emergency Use Authorization on June 17, 2020 for the AdultLife Pro Ventilator, a life-saving respiratory device the company developed in response to the COVID-19 pandemic. The AdultLife Pro Ventilator is a fully functional ventilator that provides respiratory support to patients with pneumonia, acute respiratory distress syndrome (ARDS), and other complications caused by COVID-19. This technology has proven to be crucial in treating hospitalized patients with respiratory complications caused by the virus, and the AdultLife Pro Ventilator is unique in its portability, low cost, and ease of manufacturing. Its internal battery and air pump make it uniquely suited to the emergency conditions caused by COVID-19.

“If you look at the list of ventilators that have received emergency approval from the FDA during COVID-19, you’ll see companies like NASA, GE and Philips,” says Kindall Palmer, co-founder and CEO of NeoNatal Rescue. “It’s pretty cool that a small, Utah-based organization that we started as a bunch of college students a few years ago developed a medical device that made it onto this list and will go on to save the lives of COVID-19 patients.”